Boehringer Ingelheim partners with Lifebit to detect global infectious disease outbreaks
Utilising the Lifebit REAL platform, insights into the latest infectious disease outbreaks allow Boehringer Ingelheim's R&D efforts to be prioritised accordingly.
- Utilising the Lifebit REAL platform, insights into the latest infectious disease outbreaks allow Boehringer Ingelheim's R&D efforts to be prioritised accordingly.
- Researchers from both organisations will work side-by-side to combine real-world evidence and the latest AI algorithms to identify infectious disease outbreaks and respond accordingly.
- Lifebit REAL uses advanced analytic capabilities to automatically notify users of relevant outbreaks, such as transboundary disease spread or the emergence of novel pathogens, such as COVID-19.
- Dr. Eric Haaksma, Head of Animal Health Global Innovation Boehringer Ingelheim, shared: "External innovation is becoming an increasingly important aspect of our R&D playbook.